NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹198 Cr | ₹161 Cr | ₹76 Cr | ₹89 Cr | ₹72 Cr |
What is the latest Contingent Liabilities ratio of NECTAR LIFESCIENCES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹198 Cr |
Mar2023 | ₹161 Cr |
Mar2022 | ₹76 Cr |
Mar2021 | ₹89 Cr |
Mar2020 | ₹72 Cr |
How is Contingent Liabilities of NECTAR LIFESCIENCES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹198 Cr | 22.75 | |
Mar2023 | ₹161 Cr | 113.41 | |
Mar2022 | ₹76 Cr | -15.46 | |
Mar2021 | ₹89 Cr | 24.86 | |
Mar2020 | ₹72 Cr | - |
Compare Contingent Liabilities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹722.9 Cr | -16.4% | -19% | -4.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,744.0 Cr | -4.2% | -7.7% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,209.0 Cr | -0.6% | -5.6% | 57.5% | Stock Analytics | |
CIPLA | ₹117,762.0 Cr | 3.3% | -4.8% | 6.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,705.3 Cr | -2.4% | -12.8% | 1.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,929.3 Cr | -0.3% | -2.1% | 24.5% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | -16.4% |
-19% |
-4.4% |
SENSEX | 0.3% |
-1.8% |
8.6% |
You may also like the below Video Courses